MARC Record from marc_columbia

LEADER: 03056cam a22005778a 4500
001 8608875
005 20221201063130.0
008 100819t20102010bcc b 001 0 eng
016 $a20109048784
020 $a9781553655084
020 $a1553655087
029 0 $aNLC$b20109048784
029 1 $aAU@$b000046301734
029 1 $aNLGGC$b329801430
029 1 $aNZ1$b13618913
035 $a(OCoLC)ocn555627797
035 $a(OCoLC)555627797
035 $a(NNC)8608875
035 $a8608875
040 $aNLC$beng$cNLC$dBTCTA$dYDXCP$dVP@$dCDX$dORX$dUUS$dEDX$dCOU$dLML$dNLGGC$dKCP$dGZQ
050 4 $aHD9665.5$b.M692 2010
055 0 $aHD9665.5$bM692 2010
082 04 $a381/.456151$222
084 $a44.06$2bcl
096 $aQV 736$bM938se 2010
100 1 $aMoynihan, Ray.$0http://id.loc.gov/authorities/names/n99804373
245 10 $aSex, lies, + pharmaceuticals :$bhow drug companies plan to profit from female sexual dysfunction /$cRay Moynihan & Barbara Mintzes.
246 3 $aSex, lies, and pharmaceuticals
260 $aVancouver ;$aBerkeley [Calif.] :$bGreystone Books ;$a[Berkeley, Calif.] :$bDistributed in the U.S. by Publishers Group West,$c[2010], ©2010.
300 $axi, 257 pages ;$c22 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references (p. 223-242) and index.
505 0 $aDifficulties or dysfunctions? -- 43 per cent -- Measuring pleasure -- Educating doctors with ski trips and strip clubs -- Viagra turns twelve -- Premature prescriptions -- Undoing the disorders -- Looking ahead.
520 $aReveals how womens' sexual difficulties are being repackaged as symptoms of a new disorder and investigates the creation of female sexual dysfunction or FSD, and the marketing machine that promises to "cure" it.
650 0 $aDrugs and sex.$0http://id.loc.gov/authorities/subjects/sh85039766
650 0 $aSexual disorders$xEconomic aspects.
650 0 $aDrugs$xMarketing.$0http://id.loc.gov/authorities/subjects/sh2005002422
650 0 $aAdvertising$xDrugs.$0http://id.loc.gov/authorities/subjects/sh85001119
650 0 $aPharmaceutical industry.$0http://id.loc.gov/authorities/subjects/sh85039713
650 12 $aDrug Industry$xeconomics.$0https://id.nlm.nih.gov/mesh/D004345Q000191
650 12 $aMarketing of Health Services$xeconomics.$0https://id.nlm.nih.gov/mesh/D008389Q000191
650 12 $aSexual Dysfunction, Physiological$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D012735Q000188
650 22 $aSexual Dysfunctions, Psychological$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D020018Q000188
650 22 $aGenital Diseases, Female$xeconomics.$0https://id.nlm.nih.gov/mesh/D005831Q000191
650 22 $aConflict of Interest$xeconomics.$0https://id.nlm.nih.gov/mesh/D016265Q000191
650 17 $aFarmaceutische industrie.$2gtt
650 17 $aGeneesmiddelen.$2gtt
650 17 $aSeksuele stoornissen.$2gtt
700 1 $aMintzes, Barbara.$0http://id.loc.gov/authorities/names/n94096380
852 00 $bbar$hHD9665.5$i.M692 2010g